Patents Assigned to Roche Diabetes Care, Inc.
  • Patent number: 10684245
    Abstract: Electrode arrangements for test elements, test elements and methods of determining sample sufficiency, monitoring fill time, establishing fill directions and/or confirming electrode coverage by a sample for test elements are disclosed. The test elements have an electrode-support substrate including a spacer having an edge defining a boundary of a capillary channel. The electrode-support substrate also includes a first electrode pair and a second electrode pair, wherein the first electrode pair is positioned between the second electrode pair.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: June 16, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Terry Beaty, Harvey Buck, Erica Diebold, Martin Gerber
  • Patent number: 10684299
    Abstract: This disclosure concerns a method and a system for quality evaluation of a handheld analytical device, wherein the device is operable by a human user in a sequence of handling steps to test an analyte in a sample fluid applied on a test element, the method comprising the steps of (a) programming a handling cycle for a robot having at least one robot arm in order to mimic the sequence of handling steps, (b) operating the device in at least one handling cycle by means of the robot, (c) monitoring the operation in step (b) by a control unit to evaluate at least one parameter influencing the quality of the device.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: June 16, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Wolfgang Schwoebel
  • Patent number: 10667734
    Abstract: A method for providing a signal quality degree associated with an analyte value measured in a continuous monitoring system is disclosed. The method includes the steps of: receiving a measured analyte value from a biosensor; determining at least two impact parameters, wherein each of the impact parameters is influenced by an operational status of the continuous monitoring system and wherein each of the impact parameters is capable of exerting an influence on the signal quality of the biosensor and wherein the influence of each of the impact parameters on the signal quality of the biosensor is expressed by a weight assigned to each of the impact parameters; and determining the signal quality degree associated with the measured analyte value as a function of the weights and the corresponding impact parameters; and providing the signal quality degree associated with the analyte value. Further methods are also disclosed.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: June 2, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Christian Ringemann
  • Patent number: 10672515
    Abstract: Methods and devices for retrospectively assessing continuous monitoring reference pattern data to determine a risk of a patient glucose level measurement taken in at least one data segment being outside a predetermined range. The methods and devices can include executing an algorithm to compare risk scores derived from reference pattern data in a currently collected data segment with risk scores of previously stored reference pattern data of previously collected data segments for a patient for assessing risk.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: June 2, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Abhishek Soni, David L. Duke
  • Patent number: 10667759
    Abstract: A method for analysing physiological measurement values of a user is proposed. The method comprises at least one data acquisition step, wherein, during the data acquisition step, physiological measurement values of the user are acquired at different measurement times and stored in a measurement data record; at least one pattern selection step, wherein, during the pattern selection step, measurement values acquired during one comparison time interval are selected as at least one comparison pattern; and at least one pattern recognition step, wherein, during the pattern recognition step, patterns corresponding to the comparison pattern are sought after in the measurement data record.
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: June 2, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: David Duke, Abhishek S. Soni, Bernd Steiger, Jürgen Rasch-Menges, Michael Brossart
  • Patent number: 10663451
    Abstract: Interchangeable inserts are provided for a storage container configured to receive a plurality of vertically oriented items, where the inserts include a body having a base, an upper surface having an upper opening, and an upstanding tubular sidewall extending between the base and the upper surface. The base and the tubular sidewall together define an interior space of the insert. The tubular sidewall has an inner surface and an outer surface, where a pair of resilient securing tabs extend laterally from the outer surface of the tubular sidewall. The securing tabs frictionally engage the storage container for releasably coupling the insert to the storage container. Further, the insert has a first vent opening extending through the tubular sidewall through which air can enter the interior space of the body.
    Type: Grant
    Filed: June 1, 2015
    Date of Patent: May 26, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Abner Joseph, Mark Offenbacher
  • Patent number: 10660556
    Abstract: A sampling element (110) for generating a sample of a body fluid is disclosed. The sampling element (110) comprises a housing (114), the housing having a chamber (122) with at least one puncture element (112) stored therein. A tip (132) of the puncture element (112) is movable through at least one puncture opening (124) of the housing (114) in order to perforate a skin portion of a user. The sampling element (110) further comprises at least one compression element (150), which is adapted to increase a pressure of the body fluid within a body tissue of the user in a region of puncturing when pressed onto the skin portion of the user. The compression element (150) is movably mounted to the housing (114). The sampling element (110) comprises at least one locking mechanism (168) for releasably locking the compression element (150) in at least two positions. The at least two positions comprise a first position (170) and a second position (172), the second position (172) being offset from the first position (170).
    Type: Grant
    Filed: June 10, 2014
    Date of Patent: May 26, 2020
    Assignee: ROCHE DIABETES CARE, INC.
    Inventor: Hans List
  • Patent number: 10660521
    Abstract: The invention provides for a medical system comprising a control unit and a medical appliance. The medical appliance comprises: a first processor and a monitoring system for measuring an analyte concentration subcutaneously. The control unit comprises a second processor and a second memory with a persistent partition and an application partition containing a medical application and application data comprising a medical data entry. The medical application backs up the application data as archived data in the persistent partition. The first processor is programmed to: record the analyte concentration, generate the medical data entry using the analyte concentration, and transfer the medical data entry to the control unit. The second memory further contains an operating system operable for de-installing the medical application without deleting the archived data.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: May 26, 2020
    Assignee: ROCHE DIABETES CARE, INC
    Inventors: Stefan Riebel, Kai-Oliver Schwenker, Ralf Schmitz, Carsten Mueglitz, Thomas Eissenloeffel
  • Patent number: 10653445
    Abstract: A sensor insertion assembly comprising a sensor cartridge having an insertion needle and a sensor within a sterile capsule. The sensor insertion assembly further comprises an inserter comprising a chamber for receiving the sensor cartridge, wherein the inserter further comprises an insertion mechanism operable for actuating the insertion needle for inserting the sensor into a subject. The sensor cartridge is removable from the chamber. The sensor cartridge is operable for shielding the insertion needle upon removal of the sensor cartridge from the chamber.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: May 19, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Stephan-Michael Frey, Oliver Kube, Helmut Walter, Wolfgang Heck
  • Publication number: 20200152335
    Abstract: A method is described herein to detect and treat hypoglycemia. An example of this method involves the detection of hypoglycemia in a patient with a computing device, computation of a recommended carbohydrate amount to ingest by the patient with the computing device in response to said detecting the hypoglycemia, output of the recommended carbohydrate amount with the computing device, and the performance of a hypoglycemia surveillance with the computing device to determine whether the recommended carbohydrate amount remedied the hypoglycemia.
    Type: Application
    Filed: January 9, 2020
    Publication date: May 14, 2020
    Applicants: Roche Diabetes Care, Inc., Roche Diagnostics International AG
    Inventors: Gilles Prodhom, Bernhard Teupe, Alan Greenburg, Maury Zivitz
  • Publication number: 20200151152
    Abstract: A structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof are disclosed which implement a structured collection procedure based on a medical use case and/or question which provides at least one or more parameters defining entry criterion, a schedule of events, adherence criterion, and exit criterion. The entry criterion establish conditions needed to be met prior to obtaining biomarker data from the patient. Each event can include one or more of a performance time, patient guidance to perform the event, a request for information from the patient a request for patient action, and a request for collection of biomarker data from the patient. The adherence criterion can be used to assess whether an event performed is acceptable to addressing the medical use case and/or question, and the exit criterion establishes conditions needed to be met prior to exiting the collection procedure.
    Type: Application
    Filed: January 7, 2020
    Publication date: May 14, 2020
    Applicant: Roche Diabetes Care, Inc.
    Inventors: P. Douglas Walling, Juergen Rasch-Menges, Stefan Weinert, Steven Bousamra, Abhishek S. Soni, Christoph Eisenhardt
  • Publication number: 20200147638
    Abstract: A slot die shim for use with a slot die, the slot die shim including a first channel configured to receive a first coating, a second channel configured to receive a second coating, and a third channel configured to receive a third coating. The slot die shim simultaneously dispenses the first coating through the first channel, the second coating through the second channel, and the third coating through the third channel onto a substrate. The coatings can be applied at different flow rates and include different test reagents. A vacuum force is applied to the first, second, and third coatings to control a width and a thickness of each of the coatings and a gap or distance between the coatings. The first, second, and third coatings are placed near one another or directly in contact with one another to minimize the area required for the coatings.
    Type: Application
    Filed: April 10, 2018
    Publication date: May 14, 2020
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Harvey B. Buck, JR., Randall K. Riggles, Thomas D. Hahn, Mike Limbaugh, Timothy Owens
  • Patent number: 10639070
    Abstract: Disclosed is an implant needle for introducing an implant into a patient. The needle has a hollow main body having a receiving portion configured to receive an implant. A taper-shaped tip portion is cut from the hollow needle main body and includes a first slant surface contiguous to an outer peripheral surface of the main body and formed at a first predetermined angle with respect to an axis of the main body. The first slant surface has an inner non-cutting edge and an outer non-cutting edge. The needle also includes a pair of second slant surfaces, each of which forms a second predetermined angle with respect to the main body axis that is larger than the first predetermined angle. Each second slant surface has an inner non-cutting edge and an outer cutting edge that is contiguous with an edge point of the tip portion. A method of manufacturing the implant needle is also disclosed.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: May 5, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Stephan-Michael Frey, Oliver Kube, Andrea Rittinghaus
  • Patent number: 10634659
    Abstract: A system for receiving and ejecting a fluid testing device test strip includes a strip connector having first and second guide rails, and divider walls each having a channel. A sled has first and second legs connected to a cross member. Each leg has a contact leg extending inwardly from a chamfered end. The first and second legs when positioned parallel to the guide rails have the contact leg captured in the divider wall channels retaining the sled in sliding contact with the guide rails for motions in loading and ejection directions. A mechanism assembly is movably connected to the fluid testing device. The cross member is coupled so operation in a first direction displaces the sled in the loading direction positioning the sled in a test strip test position, and opposite operation positions the contact legs in direct contact with and ejects the test strip.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: April 28, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Will A. Bishop, James R. Hanson, Joyce A. Trese
  • Publication number: 20200122151
    Abstract: The invention concerns an analyte meter (10) for medical tests having a meter housing (12), a strip port (14) mounted in an opening of the meter housing (12) and configured to receive a measuring part of a test strip (18), and a sealing insert (16) which is arranged within the strip port (14) and provides an insertion path for the test strip (18). For improved screening against contamination, it is proposed that the sealing insert (16) comprises a plurality of sealing elements (42) which are arranged consecutively along the insertion path, wherein each of the sealing elements (42) has a slit (46) that forms a sealed aperture for the test strip (18) to pass through.
    Type: Application
    Filed: October 16, 2019
    Publication date: April 23, 2020
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Rene Schramm
  • Patent number: 10617363
    Abstract: Methods and systems are disclosed analyzing a glucose level of a person having diabetes. The method, in at least one example, comprises receiving into a computing device a plurality of measured glucose values from a continuous glucose monitoring system coupled to a person having diabetes, analyzing the plurality of measured glucose values with a probability analysis tool on the computing device to determine a glucose threshold (gI0), and a boundary glucose value (g?) at a probability threshold where the person having diabetes requires at least a predetermined insulin dose, and comparing, with the computing device, the boundary glucose value (g?) to the glucose threshold (gI0), wherein if the boundary glucose value (g?) is greater than the glucose threshold (gI0) then the computing device performs an alert on a user interface.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: April 14, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Eric R Diebold, Alan Greenburg, David L Duke
  • Patent number: 10617340
    Abstract: The present invention includes a system for withdrawing body fluids. The system includes a drive unit having a plunger which is moved from a resting position into a lancing position in order to carry out a lancing process and a lancing unit containing a lancet with a needle. The plunger and lancet are coupled together by a form fit in order to carry out a lancing process. The invention additionally concerns a method for temporarily extending a needle from a device for withdrawing body fluid as well as a lancing unit that can be attached to the drive unit.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: April 14, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Michael Fritz, Klaus-Dieter Sacherer, Hans List, Thomas Weiss, Frank Deck, Claudio Immekus
  • Patent number: 10602969
    Abstract: A lancet magazine for use in a lancing aid is described comprising a plurality of lancets each having a lancet body at the proximal end of the lancet and a lancet tip at the distal end of the lancet, where the proximal end of the lancet points in the direction of the proximal end of the housing of the lancet magazine and the distal end of the lancet is aligned in the direction of the distal end of the housing and the lancets in the unused state are completely surrounded by the housing. Furthermore, an extension unit is movably connected to the housing in such a manner that the housing can be extended by movement of the extension unit in the direction of the distal end of the housing such that the lancet is prevented from emerging from the lancet magazine.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: March 31, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Richard Forster, Susanne Gentsch, Andreas Gorshöfer, Michael Keil, Thomas Weiss, Robert Wessel
  • Patent number: D884903
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: May 19, 2020
    Assignee: ROCHE DIABETES CARE, INC.
    Inventor: Michel A. Cadio
  • Patent number: D887420
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: June 16, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Matthias Koehler, Nils Babion, Gabriele Schoepfer, Lara Valenti, Clinton Young